SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-17-034591
Filing Date
2017-05-23
Accepted
2017-05-23 16:03:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D a17-14058_1sc13d.htm SC 13D 98199
2 EX-1 a17-14058_1ex99d1.htm EX-99.1 796152
3 EX-2 a17-14058_1ex99d2.htm EX-99.2 55842
  Complete submission text file 0001104659-17-034591.txt   951643
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 3711 SOUTH MOPAC EXPRESSWAY, STE 100 AUSTIN TX 78746 512-901-0900
Mirna Therapeutics, Inc. (Subject) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89131 | Film No.: 17863761
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25 FIRST STREET, SUITE 303 CAMBRIDGE MA 02141
Business Address 25 FIRST STREET, SUITE 303 CAMBRIDGE MA 02141 617-588-2600
SYNLOGIC, INC. (Filed by) CIK: 0001614170 (see all company filings)

IRS No.: 465311566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D